Systematic Review and Meta-Analysis in Randomized Controlled Trials of Anti-Hypertensive Drugs and the Risk of Cancer

This paper evaluates the potential carcinogenicity of anti-hypertensive medications by performing a meta-analysis on the risk of cancer associated with their use. The analysis incorporated data from 12 studies, encompassing a total of 16,711,997 observations, and focused on randomized controlled trials of anti-hypertensive drugs. The primary objective was to compare the cancer risk across different classes of these medications while considering their blood pressure-lowering effects. The meta-analysis employed a random-effects model to synthesize the results. The mean effect size was found to be 1.178, with a 95% confidence interval ranging from 1.027 to 1.351. A Z-test conducted to test the null hypothesis that the mean effect size equals 1 yielded a Z-value of 2.343 and a p-value of less than 0.019, leading to the rejection of the null hypothesis. This indicates a statistically significant association between the use of anti-hypertensive drugs and an increased risk of cancer. The heterogeneity among the included studies was significant, as evidenced by a Q-statistic of 85.118 with 11 degrees of freedom and a p-value of less than 0.001. The I-squared statistic was 87%, suggesting that 87% of the variance in observed effects was due to differences in true effects rather than sampling error. The tau-squared value, representing the variance of true effect sizes, was 0.040 in log units, while tau, the standard deviation of true effect sizes, was 0.201 in log units. Assuming a normal distribution of true effects, the prediction interval for the true effect size was estimated to be between 0.733 and 1.894, meaning that the true effect size in 95% of all studies would fall within this range. Overall, the findings suggest a potential risk of cancer associated with anti-hypertensive drugs, which warrants careful consideration when weighing their benefits and risks. The computations for the analysis were conducted using Comprehensive Meta-Analysis.

Authors

Institutions

Publication Details

Journal
African Journal of Advances in Science and Technology Research
Published
2024-12-03
DOI
https://doi.org/10.62154/ajastr.2024.017.010456
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systematic Review and Meta-Analysis in Randomized Controlled Trials of Anti-Hypertensive Drugs and the Risk of Cancer

Nama’a Audi, Bilkisu Maijamaá, M.U. Adehi, Abdullahi Adamu Ja'e et al.
African Journal of Advances in Science and Technology Research
Hormonal Regulation and Hypertension
article

Systematic Review and Meta-Analysis in Randomized Controlled Trials of Anti-Hypertensive Drugs and the Risk of Cancer

Nama’a Audi, Bilkisu Maijamaá, M.U. Adehi, Abdullahi Adamu Ja'e, Nweze Obini Nwaze
article en

Abstract

This paper evaluates the potential carcinogenicity of anti-hypertensive medications by performing a meta-analysis on the risk of cancer associated with their use. The analysis incorporated data from 12 studies, encompassing a total of 16,711,997 observations, and focused on randomized controlled trials of anti-hypertensive drugs. The primary objective was to compare the cancer risk across different classes of these medications while considering their blood pressure-lowering effects. The meta-analysis employed a random-effects model to synthesize the results. The mean effect size was found to be 1.178, with a 95% confidence interval ranging from 1.027 to 1.351. A Z-test conducted to test the null hypothesis that the mean effect size equals 1 yielded a Z-value of 2.343 and a p-value of less than 0.019, leading to the rejection of the null hypothesis. This indicates a statistically significant association between the use of anti-hypertensive drugs and an increased risk of cancer. The heterogeneity among the included studies was significant, as evidenced by a Q-statistic of 85.118 with 11 degrees of freedom and a p-value of less than 0.001. The I-squared statistic was 87%, suggesting that 87% of the variance in observed effects was due to differences in true effects rather than sampling error. The tau-squared value, representing the variance of true effect sizes, was 0.040 in log units, while tau, the standard deviation of true effect sizes, was 0.201 in log units. Assuming a normal distribution of true effects, the prediction interval for the true effect size was estimated to be between 0.733 and 1.894, meaning that the true effect size in 95% of all studies would fall within this range. Overall, the findings suggest a potential risk of cancer associated with anti-hypertensive drugs, which warrants careful consideration when weighing their benefits and risks. The computations for the analysis were conducted using Comprehensive Meta-Analysis.

African Journal of Advances in Science and Technology ResearchVol. 17(1)
Federal University Lafia (NG), Nasarawa State University (NG)
Good health and well-being
Openalex Percentile: Top 65%
Hormonal Regulation and Hypertension
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.